Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-20 4:41 pm Purchase | 2025-06-17 | 13D | 180 Life Sciences Corp. ATNF | Blair Jordan | 1,900,812 31.700% | 179,646 (+10.44%) | Filing History |
| 2025-05-15 4:21 pm Purchase | 2025-03-31 | 13G | 180 Life Sciences Corp. ATNF | Anson Funds Management LP | 245,750 4.500% | 20,479 (+9.09%) | Filing History |
| 2025-05-14 3:02 pm Purchase | 2025-03-31 | 13G | 180 Life Sciences Corp. ATNF | Ayrton Capital LLC | 247,105 4.550% | 247,105 (New Position) | Filing History |
| 2025-04-30 5:56 pm Purchase | 2025-04-28 | 13D | 180 Life Sciences Corp. ATNF | Blair Jordan | 1,721,166 30.200% | 1,318,000 (+326.91%) | Filing History |
| 2025-04-16 4:15 pm Purchase | 2025-04-09 | 13G | 180 Life Sciences Corp. ATNF | Amtrust Financial Services Inc. AFSI | 509,707 9.800% | 509,707 (New Position) | Filing History |
| 2025-04-11 6:05 pm Purchase | 2025-03-27 | 13D | 180 Life Sciences Corp. ATNF | ELRAY RESOURCES INC. ELRA | 4,318,000 52.800% | 4,318,000 (New Position) | Filing History |
| 2025-02-25 5:35 pm Purchase | 2025-02-20 | 13D | 180 Life Sciences Corp. ATNF | Blair Jordan | 403,166 10.500% | 403,166 (New Position) | Filing History |
| 2025-02-14 6:36 pm Purchase | 2024-12-31 | 13G | 180 Life Sciences Corp. ATNF | Anson Funds Management LP | 225,271 7.100% | 225,271 (New Position) | Filing History |
| 2025-02-13 1:01 pm Purchase | 2024-12-31 | 13G | 180 Life Sciences Corp. ATNF | Ayrton Capital LLC | 334,742 9.900% | 334,742 (New Position) | Filing History |
| 2025-01-10 5:00 pm Purchase | 2024-12-27 | 13D | 180 Life Sciences Corp. ATNF | Anthony Brian Goodman | 4,318,000 57.600% | 4,318,000 (New Position) | Filing History |
| 2025-01-03 8:08 pm Purchase | 2024-12-27 | 13G | 180 Life Sciences Corp. ATNF | Mitchell P. Kopin | 165,293 4.990% | 165,293 (New Position) | Filing History |
| 2024-11-14 3:53 pm Purchase | 2024-09-30 | 13G | 180 Life Sciences Corp. ATNF | Armistice Capital, LLC | 53,935 4.990% | 53,935 (New Position) | Filing History |
| 2024-10-18 5:00 pm Purchase | 2024-09-05 | 13G | 180 Life Sciences Corp. ATNF | Feldmann Marc | 90,532 8.600% | 90,532 (New Position) | Filing History |
| 2024-02-14 3:27 pm Purchase | 2023-12-31 | 13G | 180 Life Sciences Corp. ATNF | Armistice Capital, LLC | 58,552 9.990% | 58,552 (New Position) | Filing History |
| 2023-04-14 5:00 pm Purchase | 2022-12-23 | 13D | 180 Life Sciences Corp. ATNF | Feldmann Marc | 7,460 3.400% | 627 (+9.17%) | Filing History |
| 2022-02-09 3:15 pm Sale | 2021-12-31 | 13G | 180 Life Sciences Corp. ATNF | The Vanguard Group | 2,643 2.950% | -461 (-14.85%) | Filing History |
| 2022-02-09 3:15 pm Sale | 2021-12-31 | 13G | 180 Life Sciences Corp. ATNF | VANGUARD INDEX FUNDS | 2,643 2.950% | -171 (-6.08%) | Filing History |
| 2022-02-07 4:30 pm Purchase | 2021-12-31 | 13G | 180 Life Sciences Corp. ATNF | Nanchahal Jagdeep | 4,001 4.500% | 526 (+15.14%) | Filing History |
| 2021-12-13 4:21 pm Purchase | 2021-12-08 | 13D | CannBioRx Life Sciences Corp. ATNFW | Feldmann Marc | 2,834,930 8.200% | 2,834,930 (New Position) | Filing History |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | 180 Life Sciences Corp. ATNF | The Vanguard Group | 3,104 6.540% | 3,104 (New Position) | Filing History |